Search
Descriptor English: Ikaros Transcription Factor
Descriptor Spanish: Factor de Transcripción Ikaros
Descriptor factor de transcripción Ikaros
Scope note: Factor de transcripción que actúa como regulador clave de HEMATOPOYESIS. La expresión aberrante de Ikaros se ha asociado a LEUCEMIAS LINFOBLÁSTICAS.
Descriptor Portuguese: Fator de Transcrição Ikaros
Descriptor French: Facteur de transcription Ikaros
Entry term(s): Ikaros Protein
Transcription Factor, Ikaros
Tree number(s): D12.776.260.522.500
D12.776.930.375.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D051740
Scope note: A transcription factor that plays a role as a key regulator of HEMATOPOIESIS. Aberrant Ikaros expression has been associated with LYMPHOBLASTIC LEUKEMIA.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DE drug effects
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Registry Number: 148971-36-2
Public MeSH Note: 2006; IKAROS TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS & TRANSCRIPTION FACTORS 1992-2005
History Note: 2006(1992)
DeCS ID: 51013
Unique ID: D051740
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2006/01/01
Date of Entry: 2005/06/30
Revision Date: 2009/07/17
Ikaros Transcription Factor - Preferred
Concept UI M0208676
Scope note A transcription factor that plays a role as a key regulator of HEMATOPOIESIS. Aberrant Ikaros expression has been associated with LYMPHOBLASTIC LEUKEMIA.
Preferred term Ikaros Transcription Factor
Entry term(s) Ikaros Protein
Transcription Factor, Ikaros



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey